Patients who received atezolizumab in addition to standard chemotherapy lived two months longer than those treated with chemotherapy alone, according to a recent study published in the New England Journal of Medicine.
http://news.vumc.org/2018/10/25/combination-therapy-improves-small-cell-lung-cancer-survival/
![Lung cancer](/sites/default/files/drupalfiles/vanderbilt_news//lung-cancer_f_iStock-e1527188263555-300x298.jpg)